Surgical Controversies in Advanced Ovarian Cancer

1 Views
administrator
administrator
07/08/23

Bradley J. Monk, MD, FACS, FACOG; Thomas Herzog, MD; Kathleen Moore, MD; Leslie M. Randall, MD, MAS; and Oliver Dorigo, MD, PhD, debate among debulking strategies and neoadjuvant therapy in newly diagnosed advanced ovarian cancer based on evidence from the JCOG0602 trial.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next